![](/img/cover-not-exists.png)
Cost-Effectiveness Analysis of Bevacizumab plus Paclitaxel versus Bevacizumab plus Capecitabine for HER2-Negative Locally Recurrent or Metastatic Breast Cancer
Wu, Qiuji, Wang, Xinyuan, Zhang, Mengxi, Liao, Weiting, Wang, Feng, Li, QiuLanguage:
english
Journal:
Oncology Research and Treatment
DOI:
10.1159/000505932
Date:
March, 2020
File:
PDF, 221 KB
english, 2020